Micaela Quinn
PhD candidate at The University of Adelaide within the Bone and Joint Osteoimmunology laboratory. In collaboration with the Cancer Toxicities Treatment Group, I am investigating the skeletal effects of HER2-targeted breast cancer treatments and aiming to better characterise the influence of such treatments on bone health and metabolism.
Abstracts this author is presenting:
